 | • レポートコード：QYR2104Z2288 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、体外血液治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血液透析、急性透析、アフェレーシス）、用途別市場規模（重症敗血症、急性肺損傷、肝不全、心原性ショック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・体外血液治療の市場動向 ・企業の競争状況、市場シェア ・体外血液治療の種類別市場規模（血液透析、急性透析、アフェレーシス） ・体外血液治療の用途別市場規模（重症敗血症、急性肺損傷、肝不全、心原性ショック） ・体外血液治療の北米市場規模2016-2027（アメリカ、カナダ） ・体外血液治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・体外血液治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・体外血液治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・体外血液治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Fresenius Medical Care、DaVita Kidney Care、Renal Care、Dialysis Clinic、American Renal Associates、Satellite Healthcare、Atlantic Dialysis Management、Northwest Kidney Centers、Centers for Dialyssis Care、Rogosin Institute、B. Braun） ・結論 |
The extracorporeal blood treatment is a type of filtration method used to remove many toxins from the blood.
The demand for extracorporeal blood treatment is expected to upsurge owing to the growth of kidney diseases.
Market Analysis and Insights: Global Extracorporeal Blood Treatment Market
The global Extracorporeal Blood Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Extracorporeal Blood Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Extracorporeal Blood Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Extracorporeal Blood Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Extracorporeal Blood Treatment market.
Global Extracorporeal Blood Treatment Scope and Market Size
Extracorporeal Blood Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Extracorporeal Blood Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Hemodialysis
Acute dialysis
Apheresis
Segment by Application
Severe Sepsis
Acute Lung Injury
Liver Failure
Cardiogenic Shock
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Fresenius Medical Care
DaVita Kidney Care
Renal Care
Dialysis Clinic
American Renal Associates
Satellite Healthcare
Atlantic Dialysis Management
Northwest Kidney Centers
Centers for Dialyssis Care
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extracorporeal Blood Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hemodialysis
1.2.3 Acute dialysis
1.2.4 Apheresis
1.3 Market by Application
1.3.1 Global Extracorporeal Blood Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Severe Sepsis
1.3.3 Acute Lung Injury
1.3.4 Liver Failure
1.3.5 Cardiogenic Shock
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Extracorporeal Blood Treatment Market Perspective (2016-2027)
2.2 Extracorporeal Blood Treatment Growth Trends by Regions
2.2.1 Extracorporeal Blood Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Extracorporeal Blood Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Extracorporeal Blood Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Extracorporeal Blood Treatment Industry Dynamic
2.3.1 Extracorporeal Blood Treatment Market Trends
2.3.2 Extracorporeal Blood Treatment Market Drivers
2.3.3 Extracorporeal Blood Treatment Market Challenges
2.3.4 Extracorporeal Blood Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extracorporeal Blood Treatment Players by Revenue
3.1.1 Global Top Extracorporeal Blood Treatment Players by Revenue (2016-2021)
3.1.2 Global Extracorporeal Blood Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Extracorporeal Blood Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Extracorporeal Blood Treatment Revenue
3.4 Global Extracorporeal Blood Treatment Market Concentration Ratio
3.4.1 Global Extracorporeal Blood Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extracorporeal Blood Treatment Revenue in 2020
3.5 Extracorporeal Blood Treatment Key Players Head office and Area Served
3.6 Key Players Extracorporeal Blood Treatment Product Solution and Service
3.7 Date of Enter into Extracorporeal Blood Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Extracorporeal Blood Treatment Breakdown Data by Type
4.1 Global Extracorporeal Blood Treatment Historic Market Size by Type (2016-2021)
4.2 Global Extracorporeal Blood Treatment Forecasted Market Size by Type (2022-2027)
5 Extracorporeal Blood Treatment Breakdown Data by Application
5.1 Global Extracorporeal Blood Treatment Historic Market Size by Application (2016-2021)
5.2 Global Extracorporeal Blood Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Extracorporeal Blood Treatment Market Size (2016-2027)
6.2 North America Extracorporeal Blood Treatment Market Size by Type
6.2.1 North America Extracorporeal Blood Treatment Market Size by Type (2016-2021)
6.2.2 North America Extracorporeal Blood Treatment Market Size by Type (2022-2027)
6.2.3 North America Extracorporeal Blood Treatment Market Size by Type (2016-2027)
6.3 North America Extracorporeal Blood Treatment Market Size by Application
6.3.1 North America Extracorporeal Blood Treatment Market Size by Application (2016-2021)
6.3.2 North America Extracorporeal Blood Treatment Market Size by Application (2022-2027)
6.3.3 North America Extracorporeal Blood Treatment Market Size by Application (2016-2027)
6.4 North America Extracorporeal Blood Treatment Market Size by Country
6.4.1 North America Extracorporeal Blood Treatment Market Size by Country (2016-2021)
6.4.2 North America Extracorporeal Blood Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Extracorporeal Blood Treatment Market Size (2016-2027)
7.2 Europe Extracorporeal Blood Treatment Market Size by Type
7.2.1 Europe Extracorporeal Blood Treatment Market Size by Type (2016-2021)
7.2.2 Europe Extracorporeal Blood Treatment Market Size by Type (2022-2027)
7.2.3 Europe Extracorporeal Blood Treatment Market Size by Type (2016-2027)
7.3 Europe Extracorporeal Blood Treatment Market Size by Application
7.3.1 Europe Extracorporeal Blood Treatment Market Size by Application (2016-2021)
7.3.2 Europe Extracorporeal Blood Treatment Market Size by Application (2022-2027)
7.3.3 Europe Extracorporeal Blood Treatment Market Size by Application (2016-2027)
7.4 Europe Extracorporeal Blood Treatment Market Size by Country
7.4.1 Europe Extracorporeal Blood Treatment Market Size by Country (2016-2021)
7.4.2 Europe Extracorporeal Blood Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Extracorporeal Blood Treatment Market Size (2016-2027)
8.2 Asia-Pacific Extracorporeal Blood Treatment Market Size by Type
8.2.1 Asia-Pacific Extracorporeal Blood Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Extracorporeal Blood Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Extracorporeal Blood Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Extracorporeal Blood Treatment Market Size by Application
8.3.1 Asia-Pacific Extracorporeal Blood Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Extracorporeal Blood Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Extracorporeal Blood Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Extracorporeal Blood Treatment Market Size by Region
8.4.1 Asia-Pacific Extracorporeal Blood Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Extracorporeal Blood Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Extracorporeal Blood Treatment Market Size (2016-2027)
9.2 Latin America Extracorporeal Blood Treatment Market Size by Type
9.2.1 Latin America Extracorporeal Blood Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Extracorporeal Blood Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Extracorporeal Blood Treatment Market Size by Type (2016-2027)
9.3 Latin America Extracorporeal Blood Treatment Market Size by Application
9.3.1 Latin America Extracorporeal Blood Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Extracorporeal Blood Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Extracorporeal Blood Treatment Market Size by Application (2016-2027)
9.4 Latin America Extracorporeal Blood Treatment Market Size by Country
9.4.1 Latin America Extracorporeal Blood Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Extracorporeal Blood Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extracorporeal Blood Treatment Market Size (2016-2027)
10.2 Middle East & Africa Extracorporeal Blood Treatment Market Size by Type
10.2.1 Middle East & Africa Extracorporeal Blood Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Extracorporeal Blood Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Extracorporeal Blood Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Extracorporeal Blood Treatment Market Size by Application
10.3.1 Middle East & Africa Extracorporeal Blood Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Extracorporeal Blood Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Extracorporeal Blood Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Extracorporeal Blood Treatment Market Size by Country
10.4.1 Middle East & Africa Extracorporeal Blood Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Extracorporeal Blood Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Fresenius Medical Care
11.1.1 Fresenius Medical Care Company Details
11.1.2 Fresenius Medical Care Business Overview
11.1.3 Fresenius Medical Care Extracorporeal Blood Treatment Introduction
11.1.4 Fresenius Medical Care Revenue in Extracorporeal Blood Treatment Business (2016-2021)
11.1.5 Fresenius Medical Care Recent Development
11.2 DaVita Kidney Care
11.2.1 DaVita Kidney Care Company Details
11.2.2 DaVita Kidney Care Business Overview
11.2.3 DaVita Kidney Care Extracorporeal Blood Treatment Introduction
11.2.4 DaVita Kidney Care Revenue in Extracorporeal Blood Treatment Business (2016-2021)
11.2.5 DaVita Kidney Care Recent Development
11.3 Renal Care
11.3.1 Renal Care Company Details
11.3.2 Renal Care Business Overview
11.3.3 Renal Care Extracorporeal Blood Treatment Introduction
11.3.4 Renal Care Revenue in Extracorporeal Blood Treatment Business (2016-2021)
11.3.5 Renal Care Recent Development
11.4 Dialysis Clinic
11.4.1 Dialysis Clinic Company Details
11.4.2 Dialysis Clinic Business Overview
11.4.3 Dialysis Clinic Extracorporeal Blood Treatment Introduction
11.4.4 Dialysis Clinic Revenue in Extracorporeal Blood Treatment Business (2016-2021)
11.4.5 Dialysis Clinic Recent Development
11.5 American Renal Associates
11.5.1 American Renal Associates Company Details
11.5.2 American Renal Associates Business Overview
11.5.3 American Renal Associates Extracorporeal Blood Treatment Introduction
11.5.4 American Renal Associates Revenue in Extracorporeal Blood Treatment Business (2016-2021)
11.5.5 American Renal Associates Recent Development
11.6 Satellite Healthcare
11.6.1 Satellite Healthcare Company Details
11.6.2 Satellite Healthcare Business Overview
11.6.3 Satellite Healthcare Extracorporeal Blood Treatment Introduction
11.6.4 Satellite Healthcare Revenue in Extracorporeal Blood Treatment Business (2016-2021)
11.6.5 Satellite Healthcare Recent Development
11.7 Atlantic Dialysis Management
11.7.1 Atlantic Dialysis Management Company Details
11.7.2 Atlantic Dialysis Management Business Overview
11.7.3 Atlantic Dialysis Management Extracorporeal Blood Treatment Introduction
11.7.4 Atlantic Dialysis Management Revenue in Extracorporeal Blood Treatment Business (2016-2021)
11.7.5 Atlantic Dialysis Management Recent Development
11.8 Northwest Kidney Centers
11.8.1 Northwest Kidney Centers Company Details
11.8.2 Northwest Kidney Centers Business Overview
11.8.3 Northwest Kidney Centers Extracorporeal Blood Treatment Introduction
11.8.4 Northwest Kidney Centers Revenue in Extracorporeal Blood Treatment Business (2016-2021)
11.8.5 Northwest Kidney Centers Recent Development
11.9 Centers for Dialyssis Care
11.9.1 Centers for Dialyssis Care Company Details
11.9.2 Centers for Dialyssis Care Business Overview
11.9.3 Centers for Dialyssis Care Extracorporeal Blood Treatment Introduction
11.9.4 Centers for Dialyssis Care Revenue in Extracorporeal Blood Treatment Business (2016-2021)
11.9.5 Centers for Dialyssis Care Recent Development
11.10 Rogosin Institute
11.10.1 Rogosin Institute Company Details
11.10.2 Rogosin Institute Business Overview
11.10.3 Rogosin Institute Extracorporeal Blood Treatment Introduction
11.10.4 Rogosin Institute Revenue in Extracorporeal Blood Treatment Business (2016-2021)
11.10.5 Rogosin Institute Recent Development
11.11 B. Braun
11.11.1 B. Braun Company Details
11.11.2 B. Braun Business Overview
11.11.3 B. Braun Extracorporeal Blood Treatment Introduction
11.11.4 B. Braun Revenue in Extracorporeal Blood Treatment Business (2016-2021)
11.11.5 B. Braun Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Extracorporeal Blood Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hemodialysis
Table 3. Key Players of Acute dialysis
Table 4. Key Players of Apheresis
Table 5. Global Extracorporeal Blood Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Extracorporeal Blood Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Extracorporeal Blood Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Extracorporeal Blood Treatment Market Share by Regions (2016-2021)
Table 9. Global Extracorporeal Blood Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Extracorporeal Blood Treatment Market Share by Regions (2022-2027)
Table 11. Extracorporeal Blood Treatment Market Trends
Table 12. Extracorporeal Blood Treatment Market Drivers
Table 13. Extracorporeal Blood Treatment Market Challenges
Table 14. Extracorporeal Blood Treatment Market Restraints
Table 15. Global Extracorporeal Blood Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Extracorporeal Blood Treatment Market Share by Players (2016-2021)
Table 17. Global Top Extracorporeal Blood Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extracorporeal Blood Treatment as of 2020)
Table 18. Ranking of Global Top Extracorporeal Blood Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Extracorporeal Blood Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Extracorporeal Blood Treatment Product Solution and Service
Table 22. Date of Enter into Extracorporeal Blood Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Extracorporeal Blood Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Extracorporeal Blood Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Extracorporeal Blood Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Extracorporeal Blood Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Extracorporeal Blood Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Extracorporeal Blood Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Extracorporeal Blood Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Extracorporeal Blood Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Extracorporeal Blood Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Extracorporeal Blood Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Extracorporeal Blood Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Extracorporeal Blood Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Extracorporeal Blood Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Extracorporeal Blood Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Extracorporeal Blood Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Extracorporeal Blood Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Extracorporeal Blood Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Extracorporeal Blood Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Extracorporeal Blood Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Extracorporeal Blood Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Extracorporeal Blood Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Extracorporeal Blood Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Extracorporeal Blood Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Extracorporeal Blood Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Extracorporeal Blood Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Extracorporeal Blood Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Extracorporeal Blood Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Extracorporeal Blood Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Extracorporeal Blood Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Extracorporeal Blood Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Extracorporeal Blood Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Extracorporeal Blood Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Extracorporeal Blood Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Extracorporeal Blood Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Extracorporeal Blood Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Extracorporeal Blood Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Extracorporeal Blood Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Extracorporeal Blood Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Fresenius Medical Care Company Details
Table 63. Fresenius Medical Care Business Overview
Table 64. Fresenius Medical Care Extracorporeal Blood Treatment Product
Table 65. Fresenius Medical Care Revenue in Extracorporeal Blood Treatment Business (2016-2021) & (US$ Million)
Table 66. Fresenius Medical Care Recent Development
Table 67. DaVita Kidney Care Company Details
Table 68. DaVita Kidney Care Business Overview
Table 69. DaVita Kidney Care Extracorporeal Blood Treatment Product
Table 70. DaVita Kidney Care Revenue in Extracorporeal Blood Treatment Business (2016-2021) & (US$ Million)
Table 71. DaVita Kidney Care Recent Development
Table 72. Renal Care Company Details
Table 73. Renal Care Business Overview
Table 74. Renal Care Extracorporeal Blood Treatment Product
Table 75. Renal Care Revenue in Extracorporeal Blood Treatment Business (2016-2021) & (US$ Million)
Table 76. Renal Care Recent Development
Table 77. Dialysis Clinic Company Details
Table 78. Dialysis Clinic Business Overview
Table 79. Dialysis Clinic Extracorporeal Blood Treatment Product
Table 80. Dialysis Clinic Revenue in Extracorporeal Blood Treatment Business (2016-2021) & (US$ Million)
Table 81. Dialysis Clinic Recent Development
Table 82. American Renal Associates Company Details
Table 83. American Renal Associates Business Overview
Table 84. American Renal Associates Extracorporeal Blood Treatment Product
Table 85. American Renal Associates Revenue in Extracorporeal Blood Treatment Business (2016-2021) & (US$ Million)
Table 86. American Renal Associates Recent Development
Table 87. Satellite Healthcare Company Details
Table 88. Satellite Healthcare Business Overview
Table 89. Satellite Healthcare Extracorporeal Blood Treatment Product
Table 90. Satellite Healthcare Revenue in Extracorporeal Blood Treatment Business (2016-2021) & (US$ Million)
Table 91. Satellite Healthcare Recent Development
Table 92. Atlantic Dialysis Management Company Details
Table 93. Atlantic Dialysis Management Business Overview
Table 94. Atlantic Dialysis Management Extracorporeal Blood Treatment Product
Table 95. Atlantic Dialysis Management Revenue in Extracorporeal Blood Treatment Business (2016-2021) & (US$ Million)
Table 96. Atlantic Dialysis Management Recent Development
Table 97. Northwest Kidney Centers Company Details
Table 98. Northwest Kidney Centers Business Overview
Table 99. Northwest Kidney Centers Revenue in Extracorporeal Blood Treatment Business (2016-2021) & (US$ Million)
Table 100. Northwest Kidney Centers Recent Development
Table 101. Centers for Dialyssis Care Company Details
Table 102. Centers for Dialyssis Care Business Overview
Table 103. Centers for Dialyssis Care Extracorporeal Blood Treatment Product
Table 104. Centers for Dialyssis Care Revenue in Extracorporeal Blood Treatment Business (2016-2021) & (US$ Million)
Table 105. Centers for Dialyssis Care Recent Development
Table 106. Rogosin Institute Company Details
Table 107. Rogosin Institute Business Overview
Table 108. Rogosin Institute Extracorporeal Blood Treatment Product
Table 109. Rogosin Institute Revenue in Extracorporeal Blood Treatment Business (2016-2021) & (US$ Million)
Table 110. Rogosin Institute Recent Development
Table 111. B. Braun Company Details
Table 112. B. Braun Business Overview
Table 113. B. Braun Extracorporeal Blood Treatment Product
Table 114. B. Braun Revenue in Extracorporeal Blood Treatment Business (2016-2021) & (US$ Million)
Table 115. B. Braun Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Extracorporeal Blood Treatment Market Share by Type: 2020 VS 2027
Figure 2. Hemodialysis Features
Figure 3. Acute dialysis Features
Figure 4. Apheresis Features
Figure 5. Global Extracorporeal Blood Treatment Market Share by Application: 2020 VS 2027
Figure 6. Severe Sepsis Case Studies
Figure 7. Acute Lung Injury Case Studies
Figure 8. Liver Failure Case Studies
Figure 9. Cardiogenic Shock Case Studies
Figure 10. Extracorporeal Blood Treatment Report Years Considered
Figure 11. Global Extracorporeal Blood Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Extracorporeal Blood Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Extracorporeal Blood Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Extracorporeal Blood Treatment Market Share by Regions (2022-2027)
Figure 15. Global Extracorporeal Blood Treatment Market Share by Players in 2020
Figure 16. Global Top Extracorporeal Blood Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extracorporeal Blood Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Extracorporeal Blood Treatment Revenue in 2020
Figure 18. Global Extracorporeal Blood Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Extracorporeal Blood Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Extracorporeal Blood Treatment Market Share by Type (2016-2027)
Figure 22. North America Extracorporeal Blood Treatment Market Share by Application (2016-2027)
Figure 23. North America Extracorporeal Blood Treatment Market Share by Country (2016-2027)
Figure 24. United States Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Extracorporeal Blood Treatment Market Share by Type (2016-2027)
Figure 28. Europe Extracorporeal Blood Treatment Market Share by Application (2016-2027)
Figure 29. Europe Extracorporeal Blood Treatment Market Share by Country (2016-2027)
Figure 30. Germany Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Extracorporeal Blood Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Extracorporeal Blood Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Extracorporeal Blood Treatment Market Share by Region (2016-2027)
Figure 40. China Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Extracorporeal Blood Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Extracorporeal Blood Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Extracorporeal Blood Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Extracorporeal Blood Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Extracorporeal Blood Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Extracorporeal Blood Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Extracorporeal Blood Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Fresenius Medical Care Revenue Growth Rate in Extracorporeal Blood Treatment Business (2016-2021)
Figure 60. DaVita Kidney Care Revenue Growth Rate in Extracorporeal Blood Treatment Business (2016-2021)
Figure 61. Renal Care Revenue Growth Rate in Extracorporeal Blood Treatment Business (2016-2021)
Figure 62. Dialysis Clinic Revenue Growth Rate in Extracorporeal Blood Treatment Business (2016-2021)
Figure 63. American Renal Associates Revenue Growth Rate in Extracorporeal Blood Treatment Business (2016-2021)
Figure 64. Satellite Healthcare Revenue Growth Rate in Extracorporeal Blood Treatment Business (2016-2021)
Figure 65. Atlantic Dialysis Management Revenue Growth Rate in Extracorporeal Blood Treatment Business (2016-2021)
Figure 66. Northwest Kidney Centers Revenue Growth Rate in Extracorporeal Blood Treatment Business (2016-2021)
Figure 67. Centers for Dialyssis Care Revenue Growth Rate in Extracorporeal Blood Treatment Business (2016-2021)
Figure 68. Rogosin Institute Revenue Growth Rate in Extracorporeal Blood Treatment Business (2016-2021)
Figure 69. B. Braun Revenue Growth Rate in Extracorporeal Blood Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の急性肺損傷（ALI）市場規模・現状・予測（2021年-2027年） Acute lung injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema. Market Analysis and Insights: Global Acute Lung Injury Market The glob…- 世界の急性肺損傷（ALI）市場規模・現状・予測（2021年-2027年） Acute lung injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema. Market Analysis and Insights: Global Acute Lung Injury Market The glob…
- 世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年） Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyr…
- 世界の急性腎不全治療市場規模・現状・予測（2021年-2027年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…
- 世界の急性腎不全治療市場規模・現状・予測（2021年-2027年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…